Skip to Main Content

Paper Details

Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and Neuroenhancement.
Ophthalmol Sci
3
2023
Author NameAffiliation
Jeffrey L GoldbergSpencer Center for Vision Research, Byers Eye Institute, Stanford University
Jeffrey L GoldbergUniversity of California San Diego
Jeffrey L GoldbergBascom Palmer Eye Institute, University of Miami Miller School of Medicine
Byron L LamBascom Palmer Eye Institute, University of Miami Miller School of Medicine
Thomas A AlbiniBascom Palmer Eye Institute, University of Miami Miller School of Medicine
  • 1 - 5

Datasets